振东制药(300158.SZ)：拟与专业投资机构共同投资设立基金

Core Viewpoint - Zhendong Pharmaceutical (300158.SZ) has signed a partnership agreement with several investment entities to enhance its strategic development and competitiveness in the biopharmaceutical sector while managing investment risks effectively [1] Group 1: Investment Details - The company will act as a limited partner, committing a capital contribution of 30 million RMB, which represents a 28.5687% stake in the partnership [1] - The partnership involves collaboration with Hainan Longmen Private Equity Fund Management Partnership, Wen Nuo Yao, Beijing New Medical Consulting Co., Ltd., and Shanghai Vino Run Cheng Pharmaceutical Technology Co., Ltd. [1] Group 2: Strategic Objectives - The primary focus of the investment will be in the biopharmaceutical field, aiming to leverage professional investment institutions' strengths and resources for long-term returns [1] - The initiative is designed to integrate various resources to enhance the company's overall competitiveness without affecting its daily operations and development [1]